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Ion channels are crucial components of cellular excitability and are involved in many
neurological diseases. This review focuses on the sodium leak, G protein-coupled
receptors (GPCRs)-activated NALCN channel that is predominantly expressed in neurons
where it regulates the resting membrane potential and neuronal excitability. NALCN is part
of a complex that includes not only GPCRs, but also UNC-79, UNC-80, NLF-1 and src family
of Tyrosine kinases (SFKs). There is growing evidence that the NALCN channelosome
critically regulates its ion conduction. Both in mammals and invertebrates, animal models
revealed an involvement in many processes such as locomotor behaviors, sensitivity to
volatile anesthetics, and respiratory rhythms. There is also evidence that alteration in
this NALCN channelosome can cause a wide variety of diseases. Indeed, mutations in
the NALCN gene were identified in Infantile Neuroaxonal Dystrophy (INAD) patients,
as well as in patients with an Autosomal Recessive Syndrome with severe hypotonia,
speech impairment, and cognitive delay. Deletions in NALCN gene were also reported in
diseases such as 13q syndrome. In addition, genes encoding NALCN, NLF- 1, UNC-79, and
UNC-80 proteins may be susceptibility loci for several diseases including bipolar disorder,
schizophrenia, Alzheimer’s disease, autism, epilepsy, alcoholism, cardiac diseases and
cancer. Although the physiological role of the NALCN channelosome is poorly understood,
its involvement in human diseases should foster interest for drug development in the
near future. Toward this goal, we review here the current knowledge on the NALCN
channelosome in physiology and diseases.
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INTRODUCTION
Ion channels are integral membrane proteins that allow specific
ions to pass through lipid membranes following a concentra-
tion gradient (Hille, 2001). More than 400 genes are known that
encode ion channel subunits. In addition, alternative splicing
and heteromeric assembly of different subunits increase tremen-
dously the variety of ion channels. They are involved in many
signaling and control processes in the cell as well as in patholo-
gies referred to as “channelopathies” (reviewed in Ashcroft, 2006;
Camerino et al., 2008). In addition, pharmaceutical companies
view ion channels as therapeutic targets of choice (Kaczorowski
et al., 2008; Clare, 2010). In the present review, we focus on the
Na+-leak channel (NALCN), a major player in determining the
influence of extracellular Na+ on a neuron’s basal excitability and
its modulation by hormones and neurotransmitters.
STRUCTURE OF NALCN
NALCN (also named Rb21, VGCNL-1, NA in Drosophila
melanogaster and NCA-1/2 in Caenorhabditis elegans) was first
cloned from rat brain and described by Perez-Reyes and col-
leagues who named it Rb21 (Lee et al., 1999). With the exception
of the nematode Caenorhabditis, the cnidarian Nematostella and
the sponge Amphimedon that have two related channels, there is
only one gene encoding NALCN in other organisms (Liebeskind
et al., 2012; Senatore et al., 2013). In mammals, NALCN is a 1738
amino-acids protein that forms the channel pore of the com-
plex and has a predicted topology similar to voltage-gated sodium
and calcium channels (Snutch and Monteil, 2007)(Figure 1A).
Unlike other members of the four-domain ion channel family, the
S4 transmembrane segments have fewer positive residues, espe-
cially in domains 2 and 4, possibly explaining NALCN’s voltage
insensitivity. The predicted pore region is also unique in that
its ionic selectivity motif differs from that of calcium channels
(EEEE or EEDD) and sodium channels (DEKA). NALCN’s ion
selectivity motif (EEKE) is implicated in its specific permeation
properties. With the exception of C. elegans and D. melanogaster,
alternative splicing events in the pore-forming region of inver-
tebrate NALCN result in a calcium channel-like EEEE motif or
a sodium channel-like EEKE (or EKEE) motif that remain to be
explored at the functional level (Senatore et al., 2013). These find-
ings suggest that NALCN could behave as a sodium or calcium
channel depending on the expressed isoform (Senatore et al.,
2013).
In humans, the gene encoding NALCN is located on chro-
mosome 13q33.1 and comprises at least 44 exons (43 cod-
ing exons). Several splice variants were identified during our
cloning step and by database scanning (unpublished results
Figure 1B). Alternative splicing events were found in the intra-
cellular loop linking domains 2 and 3 and in the carboxy-
terminus region. Interestingly, there is a long non-coding RNA
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FIGURE 1 | Predicted molecular make-up of NALCN. The predicted
structure of NALCN is similar to α/α1 subunits of voltage-gated Na+ and
Ca2+ channels (Lee et al., 1999). (A) It has four homologs repeats
(domains I–IV) each composed of six transmembrane segments (S1–6).
Four pore-forming loops (P-loops) spanning from S5 to S6 make up the
ion selectivity filter. The intracellular loop linking domains I and II of
NALCN interacts with M3R and molecular determinants involved in the
regulation by CaSR are located in the carboxy-terminus (Swayne et al.,
2009; Lu et al., 2010). The S5/P loop/S6 segment of transmembrane
domain II is required for the interaction with NLF-1 (Xie et al., 2013). (B)
Alternative events (shown in green) are detected in the intracellular loop
linking domains II and III, in the P-loops of domains II and III, as well as
in the carboxy-terminus (Senatore et al., 2013; data not shown).
Mutations found in patients with INAD and an autosomal recessive
syndrome with severe hypotonia, speech impairment, and cognitive delay
are shown (Al-Sayed et al., 2013; Koroglu et al., 2013).
(lncRNA) gene named NALCN-AS1 partially overlapping with
NALCN on the reverse strand (Gene ID: 100885778; http://
www.ncbi.nlm.nih.gov/). lncRNAs are thought to function in
various cellular contexts, including post-transcriptional regu-
lation, post-translational regulation of protein activity, orga-
nization of protein complexes, cell–cell signaling, as well as
recombination (reviewed in Geisler and Coller, 2013; Sabin
et al., 2013). Importantly, lncRNAs would be associated with a
wide range of neurodevelopmental, neurodegenerative and psy-
chiatric diseases, as well as brain cancer (reviewed in Barry,
2014). The specific function of NALCN-AS1 remains to be
elucidated.
NALCN FUNCTION
GATING PROPERTIES
The first functional characterization of NALCN was described
by Ren and colleagues, who identified NALCN as the chan-
nel responsible for a tetrodotoxin (TTX)-resistant sodium leak
current in mouse hippocampal neurons (Lu et al., 2007). In
Nalcn knockout mice, they found that hippocampal neurons were
hyperpolarized by∼10mV compared to wild-typemice (Lu et al.,
2007). They concluded that NALCN would contribute to the
resting membrane potential in these neurons by eliciting a depo-
larizing current to counterbalance the hyperpolarizing current
induced by two-pore potassium channels (reviewed in Ren, 2011;
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Lu and Feng, 2012). A similar NALCN-like channel activity was
described in neurons from L. stagnalis and C. elegans (Lu and
Feng, 2011; Xie et al., 2013). Contrasting with these data, NALCN
does not conduct a background current but rather drives an
acetylcholine-activated sodium current in the MIN-6 cell line, a
pancreatic β-cell model (Swayne et al., 2009). This acetylcholine-
activated NALCN current requires the M3 muscarinic receptor
(M3R) and occurs though a G protein-independent, Src family
of tyrosine kinases (SFK)-dependent pathway. Similarly, NALCN
current was found to be activated by substance P (SP) and
neurotensin through a SFK-dependent pathway in mouse hip-
pocampal and ventral tegmental area neurons (Lu et al., 2009).
It is not clear why NALCN behaves as a leak channel (e.g., looks
like spontaneously active) in neuronal cells and not in MIN-6
cells and whether NALCNmay be considered as a GPCR-activated
channel with a cell type-dependent basal activity or as a constitu-
tively open channel regulated by GPCRs. Although these studies
provide the first demonstration for the functional properties and
regulation of NALCN channels, much remains to be determined
about the functionality of NALCN and the mechanism(s) respon-
sible for its activation. Indeed, it has also been hypothesized that
NALCNmay not be an ion channel per se but rather an ion sensor
(Senatore and Spafford, 2013). Discordance in the field indicates
that more work is clearly required to reveal the real “channel”
identity of NALCN. In the context of this review, we will consider
NALCN as a pore-forming subunit.
THE NALCN CHANNELOSOME
Like many ion channels, NALCN is associated with several pro-
teins to form a larger channel complex (Figure 2, Table 1). These
interacting proteins are involved in the folding, stabilization,
cellular localization, and activation of NALCN.
UNC-80
UNC-80 (also named KIAA1843, c2orf21) is located on human
chromosome 2q34 and has at least 45 exons. UNC-80 is a large
protein of about 3300 amino acids without any predicted trans-
membrane segments or particular functional domains. UNC-80
contributes to the neuronal localization and/or stabilization of
NALCN channel in C. elegans and D. melanogaster (Jospin et al.,
2007; Yeh et al., 2008; Lear et al., 2013). In addition, UNC-80
acts as a scaffold protein for the SFKs and UNC-79. In fact,
NALCN can interact with UNC-80 in the absence of UNC-79 and
UNC-79 can interact with UNC-80 in the absence of NALCN.
The interaction of NALCN and UNC-80 is required for the
NALCN activation/inhibition by GPCRs in neurons (Wang and
Ren, 2009; Lu et al., 2010). Similar to NALCN, databases indicate
the existence of several UNC-80 splice variants.
UNC-79
UNC-79 (also named KIAA1409) is located on human chro-
mosome 14q32.12 and has at least 48 exons. UNC-79 is also
a large protein (∼2800 amino acids) without any predicted
FIGURE 2 | Schematic representation of the NALCN channelosome.
The NALCN ion channel interacts with the M3 muscarinic receptor (M3R)
that activates the channel through a G protein-independent and Src
Family of Tyrosine Kinases (SFK)-dependent pathway upon activation by
acetylcholine (Swayne et al., 2009). UNC-80 interacts with NALCN and
SFKs and acts as a scaffolding protein (Wang and Ren, 2009; Lu et al.,
2010). In addition, UNC-80 is involved in the expression levels of NALCN
and UNC-79 as well as their neuronal localization (Jospin et al., 2007;
Yeh et al., 2008). UNC-79 interacts with UNC-80 but not NALCN and is
involved in the expression levels and the neuronal localization of NALCN
and UNC-80 (Yeh et al., 2008). CaSR was found to regulate NALCN
channel activity by an uncharacterized mechanism involving G-proteins
activation and UNC-80 (Lu et al., 2010). For clarity, NLF-1, an endoplasmic
reticulum-resident protein that interacts with NALCN and is possibly
involved in its folding is shown apart. It is not known whether the
interactions mentioned above are direct or not.
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Table 1 | Genes involved in the NALCN channelosome and their known roles.
Gene Cytogenetic location Coordinates (GRCh37 genome assembly) Gene product function References
NALCN 13q33.1 101,706,129–102,068,812 Ion channel Lu et al., 2007, 2009; Swayne
et al., 2009
UNC-80 2q34 210,636,716–210,864,023 Scaffold protein for the SFKs and
UNC-79
Wang and Ren, 2009; Lu
et al., 2010
Neuronal localization Jospin et al., 2007; Yeh et al.,
2008
UNC-79 14q32.12 93,799,565–94,174,222 Expression level of NALCN and
UNC-80
Humphrey et al., 2007; Yeh
et al., 2008; Lu et al., 2010
Neuronal localization Yeh et al., 2008
NLF-1 13q33.3 107,822,318–108,519,083 Expression level of NALCN Xie et al., 2013
CHRM3 1q43 239,549,876–240,078,750 NALCN activator Swayne et al., 2009
SRC 20q12-q13 35,973,088–36,033,835 Tyrosine kinase Lu et al., 2009; Swayne et al.,
2009
transmembrane segments or particular functional domains.
UNC-79 was found to be involved in regulating the neuronal
localization of the NALCN channel complex both in C. elegans
andD. melanogaster (Humphrey et al., 2007; Yeh et al., 2008; Lear
et al., 2013). UNC-79 has been found to regulate the expression
level of UNC-80 and, as a pair, UNC-79 and UNC-80 regulate
the expression level of NALCN. This likely occurs through a post-
transcriptional mechanism as no difference in the corresponding
mRNA levels was found (Humphrey et al., 2007; Yeh et al., 2008).
This regulation may not be conserved in mammals. As a matter
of fact, Unc-79 mutant mice lack detectable levels of the UNC-80
protein but NALCN is still present (Lu et al., 2010; Speca et al.,
2010). Another difference between invertebrates and mammals
concerns the redundant functions of these proteins. Indeed, in
D. melanogaster, transgenic expression of NALCN, UNC-79, or
UNC-80 does not relieve the requirement for the other sub-
units while, in mouse primary neurons, UNC-80 can bypass the
requirement for UNC-79 (Lu et al., 2010; Lear et al., 2013).
NLF-1
NLF-1 (NCA Localization Factor 1, also named FAM155A) is
an endoplasmic reticulum (ER) resident protein of around
438-468 amino-acids, depending on the species, that interacts
with NALCN and promotes its neuronal localization in C. ele-
gans (Xie et al., 2013). The gene encoding NLF-1 is located on
human chromosome 13q33.3 and contains 3 exons. An intronic
and non-coding transcript gene, FAM155A-IT1, is described on
the same strand (Gene ID: 100874375; http://www.ncbi.nlm.nih.
gov/) with no known function. In C. elegans, the loss of function
of nlf-1 results in a reduced leak current and a hyperpolarized
resting membrane potential in premotor interneurons. NLF-1
function is conserved across species as the mouse homolog func-
tionally substitutes to the C. elegans one. In addition, knockdown
of the D. melanogaster ortholog gene, CG33988 results in simi-
lar phenotypes as for na (see below; Ghezzi et al., 2014). Also,
knockdown ofNlf-1 in primarymouse cortical cultures effectively
reduced the background Na+ current. It has been postulated that
NLF-1 could function as a chaperone to facilitate the folding
and assembly of NALCN channels. This interaction involves the
second transmembrane domain of NALCN and requires its S5/P
loop/S6 segment. The topology of NLF-1 is predicted to have one
single transmembrane domain within 40 residues of the carboxy-
terminus and lack known amino-terminal signal sequences. There
are putative ER retention motifs (RXR) at the amino-terminus
region. nlf-1 is expressed in sensory neurons, interneurons, and
excitatory motor neurons in C. elegans. Endogenous UNC-79
level is also significantly decreased in nlf-1mutants but the NLF-1
level is unaffected by the absence of UNC-79 and UNC-80. In
humans, there is another gene homologous to NLF-1, FAM155B
that is localized to Xq13.1 and encodes for a putative protein of
473 amino-acids. It is not known if this putative protein belongs
to the NALCN channel complex. Both NLF-1 and FAM155B have
a cysteine-rich domain (CRD) involved in signal transduction in
other proteins (Pei and Grishin, 2012). In addition, these two pro-
teins are related to Mid1, a fungal stretch-activated calcium chan-
nel component that forms a complex with the transmembrane
calcium channel Cch1 (Maruoka et al., 2002).
G protein-coupled receptors (GPCRs)
In addition to its baseline activity, NALCN activity is
enhanced/modulated by several GPCRs. Acetylcholine-induced
NALCN current requires the interaction of NALCN and M3R
proteins through the 1–2 loop of NALCN and the i3 and
carboxy-terminus of M3R (Swayne et al., 2009). Other GPCRs,
the Neurokinin 1 receptor (NK1R) and a neurotensin receptor
that remains to be identified, activate NALCN upon the binding
of their ligands SP and neurotensin in primary mouse pyramidal
hippocampal neurons and dopaminergic neurons from the
ventral tegmental area (Lu et al., 2009). However, whether NK1R
interacts with NALCN remains to be shown. This raises the
possibility that several GPCRs may activate NALCN and the chal-
lenge to determine the repertoire of NALCN-activating GPCRs
persists. A full analysis of the literature gives some clues on this
point. For example, it has been reported that 5-HT modulates
a non-selective leak current involved in the resting membrane
potential in the pre-Bötzinger complex and motor neurons
likely through activation of the 5-HT2A receptor (Ptak et al.,
2009). Also, a cation conductance activated by glutamatergic
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metabotropic receptors through a G protein-independent path-
way was described in CA3 hippocampal pyramidal neurons
(Guerineau et al., 1995). In addition to its activation by several
GPCRs, NALCN was found to be inhibited by another GPCR, the
calcium-sensing receptor (CaSR) (Lu et al., 2010). This regulation
is G-protein-dependent and SFK-independent, requires UNC-80
and involves molecular determinants in the carboxy-terminal
portion of NALCN. It is not known if CaSR belongs to the
NALCN channel complex.
EXPRESSION PATTERN
NALCN is mainly expressed in the central nervous system (CNS)
but also in heart, adrenal gland, thyroid gland, lymph node, and
islets of Langerhans (both in α- and β-cells) (Lee et al., 1999; Kutlu
et al., 2009; Swayne et al., 2009; Koroglu et al., 2013; Rorsman
and Braun, 2013; see http://t1dbase.org). In the CNS, NALCN is
expressed mainly in neurons, to a lesser extent in oligodendro-
cytes, and at a very low level in astrocytes (Cahoy et al., 2008).
The temporal expression of NALCN is strongly correlated with
the expression of genes involved in synapse development and
with synaptic density in several areas of the human brain (Kang
et al., 2011; see http://hbatlas.org/). The spatial expression of
NALCN is also correlated with genes expressed in specific neural
cell types such as CALB1 (Cortical GABA interneurons), CTGF
andUNC-5C (Subplate cortical glutamatergic neurons). In inver-
tebrates, NALCN-orthologs are concentrated at the synapse in
D. melanogaster, and along the axon in C. elegans and L. stag-
nalis (Nash et al., 2002; Humphrey et al., 2007; Yeh et al., 2008;
Senatore et al., 2013). The cellular sub-localization of NALCN in
mammals is not known.
PHYSIOLOGICAL ROLES OF NALCN: LESSONS FROM
ANIMAL MODELS
Mutations in genes coding for NALCN channel proteins, both
in mammals and invertebrates, yield a wide range of pheno-
types. Functional knock-out or hypomorphic mutations in these
genes produce viable offspring (but fewer compared to wild-type)
in C. elegans and D. melanogaster, whereas it is post-embryonic
lethal in homozygous null mice (Krishnan and Nash, 1990;
Nakayama et al., 2006; Lu et al., 2007; Speca et al., 2010).While no
obvious developmental defects, including neuronal development,
were found in Nalcn and Unc-79 mutant mice, these mice die as a
result of disrupted respiratory rhythm (Lu et al., 2007, see below).
The depletion of nca1/2, unc-79 or unc-80 in C. elegans does
not result in any gross abnormality in neuronal cell body posi-
tion, neuronal processes, or fasciculation suggesting that these
mutations do not interfere with the nervous system develop-
ment (Pierce-Shimomura et al., 2008). We present below the
phenotypes observed for the animal mutants in NALCN channel
complex (Table 2).
LOCOMOTOR ACTIVITY
Wild-type C. elegans travels on a culture plate through the con-
tinuous and rhythmic propagation of sinusoidal body bends.
A simultaneous loss of both nca-1 and nca-2, or the individ-
ual loss of unc-79, unc-80 or nlf-1 results in fainting, a unique
motor deficit characterized by periodic halting during movement
(Sedensky andMeneely, 1987; Morgan et al., 1988; Rajaram et al.,
1999; Humphrey et al., 2007; Jospin et al., 2007; Xie et al., 2013).
A dysfunction of premotor interneurons was found to be the
primary cause of the failure in the initiation and maintenance
of rhythmic locomotion exhibited by fainters (Xie et al., 2013).
A “hesitant” walking phenotype (e.g., the walk is interrupted by
pauses) is also observed when na or unc-79 are invalidated in
D. melanogaster (Krishnan and Nash, 1990; Mir et al., 1997; Guan
et al., 2000; Nash et al., 2002; Humphrey et al., 2007). Conversely,
gain-of-function mutations in nca-1 lead to exaggerated body
bending, termed coiling, in C. elegans (Yeh et al., 2008).
When transitioned between solid and liquid environments,
C. elegans switch between two patterns of rhythmic locomo-
tion, crawling and swimming that are distinct in both kinematics
and pattern of muscle activity (Pierce-Shimomura et al., 2008).
A genetic screen was performed in order to find mutants capable
of normal crawling but incapable of normal swimming. unc-79,
unc-80 and nca-1;nca-2mutants were found to be paralyzed upon
immersion in liquid. The paralytic defect in swimming does not
seem to be explained by general defects in neuronal excitability,
synaptic function, or development because the fainting pheno-
type was not observed in mutants defective in voltage-gated
calcium channels or major synaptic proteins.
SENSITIVITY TO GENERAL VOLATILE ANESTHETICS (GAs) AND
ETHANOL
Several studies reported an altered sensitivity to GAs both in
invertebrates and mice mutants with some discrepancies. In
C. elegans, nca-1;nca-2, unc-79, and unc-80mutants are hypersen-
sitive to the immobilizing effect of halothane (∼2–3 fold increase
compared to controls) and other anesthetic agents (Sedensky and
Meneely, 1987; Morgan et al., 1988, 1990; Humphrey et al., 2007).
In fact, unc-79mutants are hypersensitive to thiomethoxuflurane,
methoxyflurane, chloroform, and halothane. They are also more
resistant to flurothyl and enflurane, insensitive to fluroxene and
isoflurane, andmildly more sensitive to diethylether (Morgan and
Cascorbi, 1985;Morgan et al., 1988, 1990; Humphrey et al., 2007).
By contrast, hypomorphic nahar38 and nahar85 drosophilamutants
were first described as resistant to halothane, methoxyflurane,
chloroform and trichloroethylene but not to diethylether, isoflu-
rane, and enflurane (Krishnan and Nash, 1990; Nash et al., 1991;
Campbell and Nash, 1994; Mir et al., 1997). However, it was
then reported that unc-79 and na mutants are hypersensitive
to halothane but not enflurane (Guan et al., 2000; Humphrey
et al., 2007). The fact that na mutants were first described
as resistant instead of hypersensitive may be explained by the
method used to score anesthetic sensitivity but in some cases
also by the fact that different alleles were tested. In another
study, nahar38 mutation was found to be hypersensitive to isoflu-
rane and to increase the potency with which isoflurane alters
local field potentials recorded directly from fly brains (Van
Swinderen, 2006). It was also shown that halothane presynap-
tically depresses synaptic transmission in wild-type drosophila
larvae but not in nahar38 and nahar85 mutants (Nishikawa and
Kidokoro, 1999). In mammals, heterozygous Lightweight mice,
that carry a hypomorphic mutation in Unc-79, exhibit no alter-
ation in Minimum Alveolar Concentration (MAC) in response to
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Table 2 | Physiological roles of NALCN: lessons from animal models.
Phenotype Gene Species Reference
Locomotor activity nca1/2, unc-79, unc-80, nlf-1
na,
unc-79
C. elegans
D. melanogaster
Sedensky and Meneely, 1987; Morgan
et al., 1988; Krishnan and Nash, 1990
Mir et al., 1997; Rajaram et al., 1999; Guan
et al., 2000; Nash et al., 2002; Humphrey
et al., 2007; Pierce-Shimomura et al.,
2008; Yeh et al., 2008; Xie et al., 2013
Sensitivity to volatile anesthetics nca1/2, unc-79, unc-80
na,
unc-79
unc-79
C. elegans
D. melanogaster
M. Musculus
Morgan and Cascorbi, 1985; Sedensky and
Meneely, 1987; Morgan et al., 1988, 1990
Krishnan and Nash, 1990; Nash et al.,
1991; Campbell and Nash, 1994; Mir et al.,
1997; Guan et al., 2000; Van Swinderen,
2006; Humphrey et al., 2007
Speca et al., 2010
Sensitivity to ethanol nca1/2, unc-79, unc-80
Unc-79
C. elegans
M. musculus
Morgan and Sedensky, 1995; Speca et al.,
2010
Speca et al., 2010
Respiratory rhythm Nalcn
nalcn
M. Musculus
L. stagnalis
Lu et al., 2007
Lu and Feng, 2011
Photic control of locomotion,
circadian rythms
na, nlf-1, unc-79, unc-80 D. melanogaster Campbell and Nash, 2001; Nash et al.,
2002; Lear et al., 2005, 2013; Ghezzi et al.,
2014
Abdominal morphology na,
unc-79
D. melanogaster Krishnan and Nash, 1990; Mir et al., 1997;
Nash et al., 2002; Humphrey et al., 2007
Social clustering na, nlf-1 D. melanogaster Burg et al., 2013; Ghezzi et al., 2014
Metabolism Unc-79 M. musculus Speca et al., 2010
Ethanol consumption Unc-79 M. musculus Speca et al., 2010
Systemic osmoregulation Nalcn M. musculus Sinke et al., 2011
Pacemaker activity Nalcn M. musculus Kim et al., 2012
Hyperactivity Unc-79 M. musculus Speca et al., 2010
Reproduction na D. melanogaster Krishnan and Nash, 1990
halothane, cyclopropane, or sevoflurane. However, a significant
resistance to isoflurane-induced anesthesia was described (Speca
et al., 2010).
It remains to be determined if the NALCN channel complex
is a direct target for GAs, is important for the function of cells
that contain such targets, or influences anesthesia more indi-
rectly. GAs produce a widespread neurodepression in the CNS
by enhancing inhibitory neurotransmission and reducing exci-
tatory neurotransmission. However, the action mechanisms of
GAs are not completely understood. Several ion channels and
GPCRs are affected by these compounds (reviewed in Chau, 2010;
Minami and Uezono, 2013). Of interest, it is known for a long
time that GAs such as halothane, hyperpolarize neurons by acting
on the potassium currents likely by activating two-pore potas-
sium channels (Patel et al., 1999; Gruss et al., 2004; Liu et al.,
2004). Considering that neurons from Nalcn knockout animals
exhibit a ∼10mV hyperpolarization of their resting membrane
potential, it is tempting to hypothesize that, in the case of an
observed hypersensitivity, the absence of NALCN could remove
a kind of brake for some GAs to act on their targets such as
two-pore potassium channels. In this scheme, it would explain
why, contrasting with C. elegans and D. melanogaster unc-79 and
unc-80 mutants, heterozygous lightweight mice do not display
any hypersensitivity to halothane. In fact, NALCN current and
protein were found to be still present in Unc-79 deficient mice
whereas this is not the case in C. elegans and D. melanogaster (Yeh
et al., 2008; Lu et al., 2010; Speca et al., 2010; Lear et al., 2013). An
observed resistance to other GAs implies that the NALCN chan-
nel complex is a direct target while an absence of phenotype to
other GAs would indicate that other targets beside NALCN are
involved.
In addition to GAs, alteration in ethanol sensitivity was
described in animal mutants for the NALCN channelosome.
Morgan and Sedensky, in 1995, found mutations in several genes
in C. elegans which seem to control the sensitivity to ethanol,
including unc-79 (Morgan and Sedensky, 1995). As a matter of
fact, unc-79 mutants showed a decrease by about 25% in ethanol
sensitivity. By contrast, it was recently reported that unc-79, unc-
80, and nca-1;nca-2 mutants show hypersensitivity to ethanol
(Speca et al., 2010). This hypersensitivity seems to be conserved
in mammals as heterozygous Lightweight mice exhibit a highly
significant increase in the sensitivity to the acute sedative effects
of ethanol (Speca et al., 2010). Heterozygous Lightweight mice
also present an increased ethanol preference and consumption,
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compared to wild-type mice, particularly at higher alcohol con-
centrations (Speca et al., 2010). As with GAs, the nature of the
interaction between ethanol and NALCN physiology remains to
be studied.
RESPIRATORY RHYTHM
In 2007, it was shown that the Nalcn gene is crucial for survival
in mammals (Lu et al., 2007). Homozygous Nalcn knockout mice
pups appear normal up to 12 h after birth and then die within 12 h
due to severely disrupted respiratory rhythms (Lu et al., 2007).
While wild-type mice had no abnormalities, knockout animals’
respiration was highly sporadic. Breathing was characterized by
∼5 s of apnea, followed by a burst of deep breathing for ∼5 s, and
this occurred at a rate of ∼5 apnea events/minute. Interestingly,
this pattern is reminiscent of the periodic breathing of Cheyne-
Stokes respiration found in humans with CNS damage (reviewed
in Strohl, 2003). Electrophysiological recording from the fourth
cervical nerve root that innervates the diaphragm revealed that
rhythmic electrical activity present in wild-type mice was largely
absent. Thus, the defects observed in the respiratory rhythm in
knockout mice are likely to reflect defects in electrical signaling in
the nervous system (Lu et al., 2007).
More recently, Lu and Feng, 2011, investigated the proper-
ties of a NALCN ortholog in the snail L. stagnalis and its role
in the activity of a respiratory pacemaker neuron (Lu and Feng,
2011). An in vivo investigation of its role on regulating respiratory
behavior was performed by using RNA interference approaches.
Animals in which nalcn was knocked down showed a reduced
total breathing time compared to the naïve control. The resting
membrane potential of the right pedal dorsal 1 (RPeD1) neuron
that initiates the respiratory rhythm was found to be hyperpo-
larized by ∼15mV and its rhythmic firing was abolished. Thus,
NALCN also plays a role in maintaining the respiratory activity in
adult animal. It remains to be demonstrated if NALCN plays the
same role in mammals by studying its functional properties in the
preBötzinger complex and the retrotrapezoidnucleus/parafacial
respiratory group that are involved in the respiratory rhythmo-
genesis (reviewed in Feldman et al., 2013).
PHOTIC CONTROL OF LOCOMOTION, CIRCADIAN RHYTHMS
Several studies performed with D. melanogaster mutants revealed
the NALCN channelosome as an important player of circadian
rhythms. Indeed, null na mutants display disrupted circadian
rhythm. Typically, wild-type D. melanogaster are diurnal, with a
greater proportion of their activity occurring during the daytime
but null na mutants exhibit most of their activity at night (Nash
et al., 2002). Furthermore, light enhances the climbing deficit
that is induced by GAs in these flies (Campbell and Nash, 2001).
Interestingly, the amount of NA protein does not fluctuate over
time or light cycles indicating that expression of NA is not under
circadian regulation. The phenotype seems to be the result of a
broad aberrant motor response to photic input. Central to this,
na is expressed in circadian pacemaker neurons and regulates the
output of these neurons (Lear et al., 2005). An accumulation of
Pigment-Dispersing factor (PDF), a neuropeptide essential for
robust circadian behavior, is observed in these neurons from na
mutants. This suggests that na may be required for PDF release.
It is not surprising to observe a disturbance of circadian rhythms
in na null mutants as electrical activity is an important regulator
of clock function both in invertebrates and mammals (Nitabach
et al., 2002; Belle et al., 2009). Null mutations of unc-79 and
unc-80 in D. melanogaster also display severe defects in circa-
dian locomotor rhythmicity that are indistinguishable from na
mutant phenotypes, and support the role of this channelosome
in circadian rhythms (Lear et al., 2013). Knockdown of nlf-1 in
D. melanogaster was also found to phenocopy na knockdown for
the circadian locomotion phenotype (Ghezzi et al., 2014).
SOCIAL CLUSTERING
Involvement of the NALCN channelosome in social clustering,
the natural tendency of animals of the same species to congre-
gate in close proximity within a group, was recently described.
Indeed, in a study aiming to investigate resource-independent
local enhancement (RILE) in D. melanogaster, Burg et al., 2013,
reported that nahar38 mutants display a deficient social phenotype
compared to wild-type flies (Burg et al., 2013). This deficiency is
rescued by the expression of na under the control of its native
promoter. In addition, a complete rescue of the phenotype is
also observed when na is expressed in cholinergic neurons and
a partial rescue is obtained when na is expressed in glutamater-
gic neurons. na is strongly expressed in the mushroom body, a
structure known to play a role in olfactory and visual learning and
memory and the specific blockade of na expression in this struc-
ture affects RILE behavior. Knockdown of nlf-1 inD.melanogaster
was also found to significantly suppress the social clustering
phenotype as for na (Ghezzi et al., 2014).
ABDOMINAL MORPHOLOGY (NARROW ABDOMEN )
The namutant flies are noticeably smaller than controls and their
abdomens are more slender and elongated but no obvious defor-
mity has been identified (Krishnan and Nash, 1990; Mir et al.,
1997; Nash et al., 2002). D. melanogaster bearing mutations in
unc-79 also exhibit a cylindric shaped abdomen (Humphrey et al.,
2007). It is not known if this alteration represents a developmen-
tal defect or reflects altered physiology. However, Nalcn knockout
mice neonates do not display gross abnormalities in embryonic
development, righting responses, spontaneous limb movement,
and toe/tail pinch responses (Lu et al., 2007).
METABOLISM (BODY COMPOSITION AND FOOD CONSUMPTION)
Heterozygous Lightweight mice are smaller (shorter in length
and lower in body weight) and have a leaner body composition
(increased lean tissue and decreased body fat) than wild-type
mice (Speca et al., 2010). Interestingly, heterozygous Lightweight
mice display an increased food intake in comparison with wild-
type mice of the same weight.
SYSTEMIC OSMOREGULATION (SERUM SODIUM CONCENTRATION)
A genetic analysis performed in mice demonstrated that Nalcn
is involved in systemic osmoregulation by controlling the serum
sodium concentration (Sinke et al., 2011). Furthermore, this
study reported that heterozygous Nalcn knockout mice exhibit a
significant hypernatremia.
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PACEMAKER ACTIVITY (INTERSTITIAL CELLS OF CAJAL)
With others channels, such as transient receptor potential canon-
ical (TRPC) channels, NALCN is partly responsible for the
SP-induced depolarization and regulation of the intestinal pace-
making activity in the interstitial cells of Cajal (Kim et al., 2012).
This activity generates the phasic contractions of the gastrointesti-
nal muscles. Of note, in this study, the authors found that NALCN
is not required for the basal pacemaking activity in ICCs.
POSSIBLE IMPLICATIONS OF NALCN IN HUMAN DISEASES
The NALCN channelosome was shown to be vital in mammals
(Nakayama et al., 2006; Lu et al., 2007). Considering its role in
regulating neuronal resting membrane potential, it is expected
that polymorphisms, copy number variations (CNVs) and muta-
tions in the corresponding genes may significantly impact neu-
ronal physiology and lead to diseases. In this section, we review
our current knowledge on data involving the NALCN channel
complex in human diseases. We have also included a review of
genetic data that loosely link the NALCN channel complex genes
to diseases, which may provide insights into candidate genes
involved in neuronal diseases (Table 3).
INFANTILE NEUROAXONAL DYSTROPHY (INAD)
Infantile neuroaxonal dystrophy (INAD) is a rare neurodegenera-
tive disease characterized by progressive motor, mental and visual
deterioration that begins in infancy. Onset is usually between the
age of 6 months and 3 years and death typically ensues before
the age of 10 years (reviewed in Gregory et al., 1993). Early
clinical manifestations include bilateral pyramidal tract signs,
truncal hypotonia, cognitive decline and optic atrophy.Most cases
present with distal axonal swelling and spheroid bodies in tis-
sue biopsies (Cowen and Olmstead, 1963; Morgan et al., 2006).
Originally, this recessive disorder was linked solely to mutations
in the PLA2G6 gene, which encodes the calcium-independent
phospholipase A2β (iPLA2β) enzyme, also designated iPLA2-VIA
(Khateeb et al., 2006; Morgan et al., 2006). Recently, a study
reported a mutation in the NALCN gene in two affected siblings
with additional atypical features including facial dysmorphism,
pectus carinatum, scoliosis, pes varus, zygodactyly and bilateral
cryptorchidism. The patients also exhibit cerebellar atrophy and
seizures and are still alive at 18 years-old (Koroglu et al., 2013;
also see Seven et al., 2002). The identified mutation was a C to T
conversion in NALCN coding exon 16 (c.1924C > T), creating a
premature translational termination signal at codon 642 (Q642X)
and truncated NALCN channel (Figure 1B). Interestingly, our
unpublished data indicate that this exon is alternatively spliced
resulting in the loss of one isoform but not NALCN in its entirety
and may explain why the mutation is not lethal. It remains to
be established whether this mutation results in a mRNA decay
or expression of a truncated two-domain isoform. The fact that
PL2G6 and NALCN genes mutations result in a similar disease
raises the possibility that iPLA2β could be a regulator of NALCN.
AUTOSOMAL RECESSIVE SYNDROMEWITH SEVERE HYPOTONIA,
SPEECH IMPAIRMENT, AND COGNITIVE DELAY
Mutations in the NALCN gene were recently reported in six
patients with an autosomal-recessive syndrome characterized by
Table 3 | Possible implications of the NALCN channel complex in
diseases.
Disease Gene Reference
Infantile neuroaxonal
dystrophy (INAD)
NALCN Koroglu et al., 2013
Autosomal-recessive
syndrome with severe
hypotonia, speech
impairment, and cognitive
delay
NALCN Al-Sayed et al., 2013
Cervical dystonia NALCN Mok et al., 2013
Cancer
Pancreas
Non-small cell lung
Tumor-derived endothelial
cells
Glioblastoma
NALCN
NALCN, UNC-80
NLF-1
NALCN, NLF-1
Biankin et al., 2012
Lee et al., 2013
McGuire et al., 2012
Fontanillo et al., 2012
Psychiatric disorders
Bipolar disorder
Schizophrenia
Depression
Attention-deficit/
hyperactivity disorder
with conduct disorder
NALCN, UNC-79
NALCN
NLF-1
NLF-1
Baum et al., 2008;
Askland et al., 2009;
Wang et al., 2010
Wang et al., 2010
Terracciano et al., 2010
Anney et al., 2008
Epilepsy UNC-80 Ratnapriya et al., 2010;
EPICURE Consortium
et al., 2012
Autism UNC-80 Iossifov et al., 2012
13q syndrome NALCN, NLF-1 Brown et al., 1995;
Kirchhoff et al., 2009;
Huang et al., 2012;
Lalani et al., 2013
Alzheimer’s disease UNC-80
UNC-79
Scott et al., 2003
Lee et al., 2008; Grupe
et al., 2007
Alcoholism NALCN
UNC-79
UNC-80
Wetherill et al., 2014
Lind et al., 2010
Nurnberger et al., 2001;
Schuckit et al., 2001
Restless legs syndrome NALCN Balaban et al., 2012
Primary biliary cirrhosis NLF-1 Hirschfield et al., 2009
Hypertension NLF-1 Adeyemo et al., 2009
Polyglutamine disorders NLF-1 Whan et al., 2010
severe hypotonia, speech impairment, and cognitive delay from
two large consanguineous families (Al-Sayed et al., 2013). Three
male patients (ranging from 4 to 7 years-old) from one family are
homozygous for a single nucleotide deletion c.1489delT located
in the coding region for the S4 helix from domain II (Figure 1B).
This mutation results in a frame shift creating a stop codon 21
amino-acids downstream, which likely results in the production
of a truncated protein or mRNA decay. Unless the involved exon
is alternatively spliced, it is not clear why this deletion is not
lethal as reported for Nalcn knockout mice (Lu et al., 2007).
These patients have an absence of speech development, severe
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hypotonia, chronic constipation, global developmental delay, and
facial dysmorphism which is reminiscent of infantile hypotonia
with psychomotor retardation and characteristic facies (IHPRF,
OMIM #615419). Three female patients (ranging from 9 to 17
years-old) from a second family are homozygous for a missense
mutation c.3860G > T (W1287L) in exon 34 that encodes for
the S4 helix from domain IV (Figure 1B). These patients have a
milder but similar phenotype as the first family with additional
features such as seizure disorder and hyperactivity.
CERVICAL DYSTONIA
Dystonia is a “syndrome of sustained muscle contractions, fre-
quently causing twisting and repetitive movements or abnormal
postures” (reviewed in Fahn et al., 1998). Estimates of the preva-
lence of dystonia range from ∼1:10,000 to more than 1:200
(Nutt et al., 1988; Nakashima et al., 1995; Epidemiological Study
of Dystonia in Europe Collaborative, G., 2000; Muller et al.,
2002). Clinical presentation of dystonia is heterogeneous, from
focal involvement such as cervical dystonia to generalized tor-
sional dystonia. Cervical dystonia is the most common form
of dystonia (Butler et al., 2004; Jankovic et al., 2007; Groen
et al., 2013). The majority of cervical dystonia is transmitted
in a non-Mendelian pattern, which suggests cervical dystonia is
likely a complex disease rather than monogenic form. A recent
genome-wide association study (GWAS) in 212 patients with this
form of dystonia revealed a possible association with NALCN
(Mok et al., 2013). However, this study did not find any single
nucleotide polymorphisms (SNPs) with genome-wide signifi-
cance (defined as P < 5 × 10−8) but a few clusters of possible
association (defined as P < 5 × 10−6). Six SNPs within or in
the vicinity of the NALCN gene with P-values ranging from
2.54 × 10−6 to 9.76 × 10−7 were found. Additional GWAS with
larger cohorts of patients are required since the small sample size
for this initial study was underpowered to detect loci with small
disease effects.
PSYCHIATRIC DISORDERS
Schizophrenia and Bipolar disorder
Schizophrenia (SCZ) is a chronic, severe disabling brain disor-
der characterized by abnormalities in the perception of reality. It
most commonly manifests as auditory hallucinations, delusions,
disorganized speech and thinking with significant social or occu-
pational dysfunction (reviewed in Silveira et al., 2012). Bipolar
disorder (BD), also known as manic-depressive illness, is a seri-
ous medical illness that causes shifts in a person’s mood, energy,
and ability to function (reviewed in Smith et al., 2012). Different
from the normal ups and downs that everyone goes through, the
symptoms of BD are severe. SCZ and BD affect around 1% of the
population each. Both diseases have strong inherited components
and growing evidence indicates that BD and SCZ may be closely
related.
Interestingly, theNALCN gene lies within a region on chromo-
some 13q that has shown linkage to both BD and SCZ (reviewed
in Detera-Wadleigh and McMahon, 2006). More specifically, the
correlation between NALCN mRNA expression and the SCZ-
associated gene GABRB2 in human brain (Kang et al., 2011),
along with the association between the Drosophila homolog, na
with circadian rhythms (disruptions of which are a hallmark of
BD) suggest that NALCN may play a role in these two disor-
ders (reviewed in Lenox et al., 2002). Importantly, while some
genetic studies point out NALCN as a susceptibility locus in
SCZ and BD, other studies have not concurred with these find-
ings. A GWAS performed by genotyping more than 550,000 SNPs
in two independent cohorts of European origin (for a total of
1233 patients and 1439 controls) revealed a significant association
between NALCN and BD (SNP rs9513877; Baum et al., 2008).
This finding was confirmed by Askland et al. (2009). A genome-
wide meta-analysis also identified a significant association of
NALCN (SNP rs2044117) with both SCZ and BD in cohorts of
1172 (SCZ) and 653 (BD) European-American patients (Wang
et al., 2010). However, no significant association between BD and
NALCN was found in a Finnish cohort of 723 individuals from
180 families with type I BD (Ollila et al., 2009). Furthermore,
there was no association of NALCN with SCZ in a cohort of 583
patients (Souza et al., 2011), nor in a group of 240 individuals
with treatment-resistant SCZ (Teo et al., 2012). The discrepancies
in candidate gene studies may partly result from the clinical and
genetic heterogeneity of BD and SCZ and their complex inher-
itance model, but also from methodological issues such as the
definition of clinical phenotype. More work is needed to confirm
that NALCN is a susceptibility locus in BD and SCZ.
Several findings suggest that UNC-79 and UNC-80 are also
associated with these disorders, further implicating the NALCN
channelosome with SCZ and BD. TheUNC-79 encoding gene lies
within a region on chromosome 14q that has shown linkage to
BD. Askland et al., 2009, also suggested an association between
SNP rs17125698 located at around 4Mb from the UNC-79 gene
and BD (Askland et al., 2009). Another study also reported an
association of SNP rs11622475 located in 14q32 in BD (Wellcome
Trust Case Control, C, 2007). However, this SNP is located at
around 100Mb from UNC-79. A proteomic study suggested that
UNC-80 could belong to the same protein complex as dysbindin,
a SCZ susceptibility gene product (Mead et al., 2010).
Major depressive and Attention-deficit/hyperactivity disorders
NLF-1 has been loosely associated with both major depres-
sive disorder and attention-deficit/hyperactivity disorder. Major
depressive disorder (MDD) is a syndrome characterized by a
number of behavioral, cognitive and emotional features. It is
most commonly associated with a sad or depressed mood, a
reduced capacity to feel pleasure, hopelessness, loss of energy,
altered sleep patterns, weight fluctuations, difficulty in concen-
trating and suicidal ideation (reviewed in Uher et al., 2013). A
GWAS of depression traits found a possible association between
MDD and SNPs in the vicinity of NLF-1 (SNPs rs9634463,
rs7329003, rs713548, rs9301191, and rs1924397), but statistical
significance was not reached for any gene (Terracciano et al.,
2010). Attention-deficit/hyperactivity disorder (ADHD) is char-
acterized by inattention, excessive motor activity, impulsivity and
distractibility and affects 8–12% of school-age children world-
wide (reviewed in Sharma and Couture, 2014). Individuals with
ADHD show high co-morbidity with a wide range of psychi-
atric disorders. In a study aiming to identify susceptibility loci for
ADHDwith conduct disorder, Anney et al., 2008, did not find any
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significant association with any SNP but two of the strongest asso-
ciations were found with SNPs rs10492664 and rs8002852 that are
located in the vicinity ofNLF-1 (Anney et al., 2008). Interestingly,
phenotypes observed for Nk1R knockout mice strongly parallel
abnormalities expressed by patients with ADHD and heterozy-
gous Lightweight mice are modestly but significantly hyperactive
(Speca et al., 2010; Yan et al., 2010).
EPILEPSY
Epilepsy, a very common neurological disorder, is defined by the
occurrence of unprovoked seizures caused by the synchronous
discharge of large number of neurons (reviewed in Sander, 2003;
Khan and Al Baradie, 2012). Abnormal expression or func-
tion of ion channels may be involved in the pathophysiology of
both acquired and inherited epilepsy (reviewed in Mantegazza
et al., 2010; Lerche et al., 2013). Considering the importance of
the NALCN channel complex in setting the resting membrane
potential of neurons, the NALCN channelosome gene mutations
are clear candidates for epilepsy. As mentioned in this review,
patients with INAD or an autosomal-recessive syndrome with
severe hypotonia, speech impairment, and cognitive delay have
seizures (Al-Sayed et al., 2013; Koroglu et al., 2013). Seizures
were also reported for patients with chromosome 13q deletions
in regions that contain the NALCN gene (Kirchhoff et al., 2009;
Lalani et al., 2013). Recently, a whole genome linkage analysis
in three-generations of a south Indian family who had multiple
members affected with juvenile myoclonic epilepsy (JME) found
a critical genetic interval of 24Mb between markers D2S116 and
D2S2390 (Ratnapriya et al., 2010). The UNC-80 gene lies in this
region. In addition, a region-wide linkage analysis carried out in
118 European families with an aggregation of JME indicated a sig-
nificant linkage with marker rsD2S143 located on chromosome
2q34 at around 4Mb of theUNC-80 gene (EPICURE Consortium
et al., 2012).
AUTISM
Autism Spectrum Disorders (ASDs) are neurodevelopmental dis-
orders characterized by impairments in social interaction and
communication, and the presence of restrictive and repetitive
behaviors (reviewed in Jones et al., 2014). Exome sequencing of
343 families, each with a single child on the autism spectrum and
at least one unaffected sibling, revealed de novo small indels and
point substitutions in the affected sibling (Iossifov et al., 2012).
One of the discovered mutations resulted in a truncating R518X
mutation in one copy of UNC-80, suggesting that UNC-80 is a
susceptibility locus in autistic spectrum.
13q SYNDROME
The 13q syndrome is caused by structural and functional mono-
somy of the 13q chromosomal region and was first described
in 1963 and consequently delineated as a specific syndrome in
1969 (Lele et al., 1963; Allderdice et al., 1969). Large numbers
of patients with deletions of the long arm of chromosome 13,
which includes NALCN and NLF-1, have been described in the
literature. The phenotypes of these patients varied widely. Some
showed severe malformations involving the brain, heart, kidneys,
lungs, other organ systems, and digits while others were only
mildly affected with minor dysmorphic features, developmen-
tal delay, and growth failure. The characteristic features of 13q
deletions include growth retardation with microcephaly, facial
dysmorphism, congenital heart, brain, and kidney defects (Brown
et al., 1995). Several studies addressed karyotype-phenotype cor-
relations depending on the extent of the deletions (Brown et al.,
1995; Luo et al., 2000; McCormack et al., 2002; Alanay et al.,
2005; Garcia et al., 2006; Ballarati et al., 2007; Walczak-Sztulpa
et al., 2008; Kirchhoff et al., 2009; Quelin et al., 2009). It was
reported that the severely malformed phenotype results from the
deletion of a critical region lying between markers D13S136 and
D13S147 (Brown et al., 1995). This region of around 2.3Mb
contains several genes including NALCN. Recently, a molecular-
karyotyping study reported that a female with congenital heart
defects, facial anomalies, developmental delay, and intellectual
disability had a deletion of 12.75Mb extending from 13q33.1 to
13q34 (Huang et al., 2012). The deleted region harbors 55 genes,
including NALCN and NLF-1. Another study further refined a
critical region for all CNS anomalies and neural tube defects taken
together, to a region of 1.6Mb (Kirchhoff et al., 2009). Only seven
known genes are located within this region, including NALCN.
A recent study aiming to identify rare DNA copy number variants
in cardiovascular malformations with extracardiac abnormalities
revealed the deletion of 641 kb in the NALCN gene region in 3
patients (Lalani et al., 2013). The extracardiac phenotypes of these
patients include agenesis of corpus callosum, growth retardation,
facial dysmorphism, and seizures.
ALZHEIMER’S DISEASE
Alzheimer’s disease (AD) is the most common form of dementia
and the most frequent degenerative brain disorder encountered
in old age. The risk of developing AD substantially increases after
65 years of age (reviewed in Nussbaum and Ellis, 2003). With the
exception of rare cases of early onset familial Alzheimer’s disease
caused by mutations in the amyloid precursor protein or prese-
nilins genes, the etiology of the vast majority of cases remains
misunderstood. There is evidence for substantial genetic influ-
ence (reviewed in St. George-Hyslop and Petit, 2005; Tanzi and
Bertram, 2005). A linkage analysis to detect novel AD loci from
437 families (1252 individuals) revealed a statistically significant
linkage with marker D2S2944 located in 2q34 in 31 American
families with a minimum age at onset between 50 and 60 years
(Scott et al., 2003). This marker is located at less than 4Mb from
the UNC-80 gene. Another study reported the existence of a sus-
ceptibility locus in 14q32.12 near marker D14S617 in a Caribbean
Hispanic cohort of 1161 individuals from 209 families (Lee et al.,
2008). The UNC-79 gene lies in a region at less than 3Mb from
this marker. The existence of a susceptibility locus for AD in the
vicinity of the UNC-79 gene (SNP rs11622883) was also reported
by Grupe et al., 2007, from a cohort of 1808 American-European
patients (Grupe et al., 2007).
ALCOHOLISM
Alcohol dependence is one of the most common and costly pub-
lic health problems. Several studies suggest a role of genetic
factors and few genes have been shown to be associated with alco-
hol dependence (reviewed in Morozova et al., 2014). A recent
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GWAS performed in 118 European-American families (2322 indi-
viduals) demonstrated a significant linkage of SNP rs17484734,
located in the NALCN gene, and high-risk of alcohol dependence
(Wetherill et al., 2014). Interestingly, mice that heterologously
carry a hypomorphic mutation in the Unc-79 gene voluntarily
consume more ethanol than wild-type littermates (Speca et al.,
2010). A GWAS on comorbid alcohol/nicotine dependence in
599 cases and 488 controls found SNP rs12882384 as one of
the three top findings, which is located within the UNC-79 gene
(Lind et al., 2010). Genome-wide significance was found for
joint alcohol/nicotine comorbidity but not for nicotine or alcohol
dependence alone suggesting the existence of genes that medi-
ate the combined effect of these two addictive substances. In
addition, two previous studies suggest the existence of a sus-
ceptibility locus located on chromosome 2, near the UNC-80
gene, linked to alcohol tolerance (markers D2S425, D2S434,
D2S424, D2S1323, D2S1333) and the comorbidy of alcoholism
and depression (marker DS1371) respectively (Nurnberger et al.,
2001; Schuckit et al., 2001).
RESTLESS LEGS SYNDROME
Restless legs syndrome (RLS) is a sensorimotor disorder char-
acterized by abnormal sensations in the limbs that are both
dependent on activity and time of day, such that symptoms
are promoted by rest and relieved by activity and peak in the
evening or at night (reviewed in Winkelman et al., 2013). RLS
is a genetically heterogeneous complex trait with high preva-
lence but large phenotype variability. Current theories of RLS
pathophysiology emphasize brain iron deficiency with abnormal
dopaminergic consequences, together with a strong underlying
genetic background (reviewed in Dauvilliers and Winkelmann,
2013). A recent study analyzing 11 individuals from the same
family indicated the existence of a locus on chromosome
13q, between SNPs rs2182885 and rs7333498 (around 5.3Mb
in size; Balaban et al., 2012). The NALCN gene lies in this
region.
PRIMARY BILIARY CIRRHOSIS
Primary biliary cirrhosis is a chronic granulomatous cholangitis,
characteristically associated with antimitochondrial antibodies.
Analysis of both aggregation data from families and concordance
data from twins revealed a genetic predisposition for the disease
(reviewed in Hirschfield and Gershwin, 2013). A GWAS with a
cohort of 2072 North-American individuals (536 patients and
1536 controls) was carried out by genotyping more than 300,000
SNPs (Hirschfield et al., 2009). Although this study reported the
strongest association of the disease with HLA-related genes, a sig-
nificant association was found with SNP rs2211312 in the NLF-1
gene.
HYPERTENSION AND BLOOD PRESSURE
Hypertension is a common human disease affecting over one
billion people world-wide and a major contributor to cerebrovas-
cular accidents, myocardial infarction, congestive cardiac failure
and chronic renal failure (reviewed in Zhao et al., 2013). A GWAS
performed by genotyping more than 800,000 SNPs in a sample
of 1017 African-American individuals led to the identification
of several potential loci involved in the regulation of blood
pressure (Adeyemo et al., 2009). A significant association was
found between systolic blood pressure and SNP rs9301196 located
within the NLF-1 gene.
POLYGLUTAMINE DISORDERS
Polyglutamine (polyQ)-expansions in different proteins cause at
least eleven neurodegenerative diseases includingHuntington dis-
ease and spinocerebellar ataxias (reviewed in Todd and Lim,
2013). These human diseases are caused by extreme expansion of
the repeats, which adversely impact protein structure, often caus-
ing intracellular protein aggregation and altered protein function.
Bovine NLF-1 exhibits a polymorphic polyQ tract in its sequence
(Whan et al., 2010). This polyQ tract is also found in other species
including human beings suggesting that aggregation of NLF-1
could be involved in neurodegenerative diseases.
CANCER
Biankin et al. examined pancreatic cancer genomes using exome
sequencing and copy number analysis from a cohort of 142
patients of early (stages I and II) sporadic pancreatic ductal
adenocarcinoma (Biankin et al., 2012). Analysis of genes with
non-silent mutations occurring in 2 or more individual cancers
identified 16 genes including NALCN (mutated in 4 patients).
Pathway analysis allowed not only the identification of genes
involved in mechanisms already known to be involved in cancer
but also genes known to be involved in axon guidance. This latter
finding was strengthened by the inclusion of data from another
study (Jones et al., 2008). It is tempting to speculate that NALCN
could also be involved in axon guidance.
An association of NALCN with non-small cell lung cancer
was also suggested by a study where 217,817 SNPs were geno-
typed in 348 advanced patients who received chemotherapy (Lee
et al., 2013). These genetic association studies revealed that SNP
rs9557635, located in the genomic regions of the NALCN gene,
was associated with this disease. Interestingly, this study also
reported a strongly significant association with SNP rs2371030
located 25 kb downstream to the CPS1 gene on chromosome
2q34, which contains theUNC-80 gene. Further linking the chan-
nelosome to cancer, a recent study reported an NLF-1 copy num-
ber increase in populations of tumor-derived endothelial cells
that are resistant to anti-angiogenic cancer therapies (McGuire
et al., 2012). Finally, in a search for key altered genomic regions in
human glioblastomas, Fontanillo et al., 2012, found a high corre-
lation between the malignant state and copy number alterations
in the NALCN and NLF-1 regions with a decrease in expression
level (Fontanillo et al., 2012).
CONCLUDING REMARKS AND FUTURE DIRECTIONS
IS NALCN REALLY A CHANNEL PER SE?
From a fundamental point of view, it remains unclear whether
NALCN is truly an ion channel. The early findings by Ren and
colleagues supported that NALCN was an ion channel, based
on mutations in the putative selectivity filter (EEKE) that alter
the permeation properties and the gadolinium block (EEKA) or
inhibit the observed currents in HEK-293 cells (EEEE)(Lu et al.,
2007). Further supporting this, inD. melanogaster, the expression
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of a naEEEE mutant in na neurons using the UAS-GAL4 sys-
tem did not restore the studied phenotype as nawt does (Lear
et al., 2005). However, functional expression of NALCN channel
in heterologous expression systems is difficult to obtain and these
data do not demonstrate unambiguously that NALCN is a pore
forming subunit. A clear proof of its channel activity would come
from electrophysiological data exploring NALCN channel activity
when rebuilt in lipid bilayers.
WHAT ARE THE GATING PROPERTIES OF NALCN?
The mechanism(s) that gate NALCN have yet to be established.
On one hand, NALCN channel is described as conducting a
sodium leak current in neurons both in mammals and inver-
tebrates (Lu et al., 2007; Lu and Feng, 2011; Xie et al., 2013).
On the other hand, NALCN channel also conducts a sodium
current activated by acetylcholine though the M3R in a pancre-
atic β-cell line without any evidence for a leak current (Swayne
et al., 2009). One may hypothesize that the NALCN-mediated
leak current observed in neurons may result from a constitu-
tive activity of some GPCRs (Swayne et al., 2009). In this case, it
would require UNC-80 and SFKs. However, this hypothesis may
not be valid for two main reasons. First, considering that HEK-
293 cells do not express UNC-79 and UNC-80 (Swayne et al.,
2009), the expression of NALCN alone is sufficient to observe
a sodium leak current in these cells (Lu et al., 2007). Second,
it was shown that a sodium leak current mediated by NALCN
is still present in hippocampal neurons from Unc-79 knockout
mice where UNC-80 is not detected (Lu et al., 2010). Thus, the
gating properties of NALCN remain mysterious and should be
investigated further. In keeping with this idea, the search for
additional proteins that belong to the NALCN channelosome
could give clues regarding modulation of the NALCN gating
mechanism.
WHAT IS THE REPERTOIRE OF GPCRs CAPABLE OF MODULATING
NALCN CHANNEL?
Recent studies have established that NALCN can be acti-
vated/potentiated or inhibited by different GPCRs (Lu et al.,
2009; Swayne et al., 2009; Lu et al., 2010). Therefore, one may
expect additional GPCRs to be involved in these processes.
Identification of this repertoire is an important challenge and
understanding why some GPCRs modulate NALCN, and some
others do not, would help to understand further how NALCN
is activated/regulated in neurons and how neurotransmitters and
hormones affect neuronal electrophysiological properties.
WHAT ARE THE FUNCTIONAL CONSEQUENCES OF ALTERNATIVE
SPLICING ON NALCN CHANNELOSOME GENES?
Alternative splicing events were demonstrated in many ion chan-
nels and can significantly impact their biophysical properties,
cellular localization, and functional regulations (reviewed in Noel
et al., 2011; Jan and Jan, 2012; Lipscombe et al., 2013). Alternative
splicing was identified in NALCN channelosome genes (Senatore
et al., 2013; Monteil unpublished data). The physiological conse-
quences of these alternative splicing events remain to be eluci-
dated.
ARE UNC-79, UNC-80, AND NLF-1 SPECIFIC NALCN-ANCILLARY
SUBUNITS?
In C. elegans, nlf-1, unc-79, unc-80, and nca-1;nca-2 mutants
exhibit exactly similar phenotypes and both Unc-79 and Nalcn
knockout mice die soon after birth. However, the post-natal
lethality observed in these mouse models could mask phenotypes
more specific to one subunit compared to the others. As a matter
of fact, we cannot exclude that UNC-79, UNC-80, and NLF-1
may have NALCN-independent physiological roles. Conditional
knockout mice for each component of the NALCN channelosome
would be very helpful to clarify this point.
ARE THERE MORE PROTEINS IN THE NALCN CHANNELOSOME?
The NALCN channelosome is probably not restricted to NALCN,
UNC-79, UNC-80, NLF-1, SFKs, and GPCRs. As an example,
there is another gene highly related to NLF-1, FAM155B in mam-
mals (accession number NG_021282.1). Whether the FAM155B
gene product belongs to the NALCN channel complex should be
investigated. Also, the mechanisms involved in the regulation of
the NALCN channel by CaSR are not known and could imply
a co-inclusion in the same protein complex. Some studies indi-
cate genetic interactions between nca-1;nca-2 and other genes in
C. elegans. As a matter of fact, null mutants of stomatins (unc-
1 and unc-24) and innexins (unc-7 and unc-9) were found to
restore the altered sensitivity to GAs and ethanol (Sedensky and
Meneely, 1987; Morgan et al., 1990; Morgan and Sedensky, 1995;
Sedensky et al., 2001; Humphrey et al., 2007). It was also found
that nca-1;nca-2 mutants exhibit a reduced evoked post-synaptic
current at the neuromuscular junction and this phenotype is
rescued by unc-7 mutants (Bouhours et al., 2011). However,
in this latter study, co-immunofluorescent staining experiments
do not show obvious neuronal co-localization of UNC-7 and
NCA-1/NCA-2. Thus, the reported genetic interaction between
unc-7 and nca-1;nca-2 probably reflects a functional, rather than
a physical interaction. A genetic interaction was also described
between unc-26 null mutants and unc-80 and nca-1;nca-2 (Jospin
et al., 2007). unc-26 encodes for Synaptojanin, a lipid phos-
phatase required to degrade phosphatidylinositol 4,5 bisphos-
phate (PIP2) at cell membranes during synaptic vesicle recycling
(Cremona et al., 1999). It was found that unc-80 and nca-1;nca-2
mutants ameliorate the recycling defects of synaptic vesicles as
well as the synaptic transmission in unc-26 null mutants and it
was suggested that nca-1;nca-2 function could be regulated by
PIP2 (Jospin et al., 2007). Whether Synaptojanin belongs to the
NALCN channelosome remains to be investigated. Interestingly,
NALCN and PLA2G6 mutations results in similar phenotypes in
humans suggesting that iPLA2β could be a regulator of NALCN.
Complementary techniques such as two-hybrid and immunopre-
cipitation studies followed by mass spectrometry approaches will
certainly lead to the discovery of new components of the NALCN
channelosome.
HOW IS NALCN FUNCTIONS MODULATED?
In addition to their regulation by binding partners, ion chan-
nels are known to be post-translationally modulated. For exam-
ple, ion channel complexes can be phosphorylated by a variety
of kinases which regulate their physiological roles (reviewed in
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Smart, 1997; Dai et al., 2009; Cerda et al., 2011; Scheuer, 2011;
Vacher and Trimmer, 2011). An in silico analysis of primary
amino-acid sequences of NALCN, UNC-79, UNC-80, and NLF-
1 reveals the existence of several predicted phosphorylation sites
that are conserved in mammals and for some of these sites, are
also conserved in C. elegans,D.Melanogaster, and L. Stagnalis (not
shown). The physiological relevance of the NALCN channelosome
phosphorylation, as well as the identification of the kinases
involved, remains to be explored.
IN WHICH NEURONAL SUBTYPE(S) IS NALCN EXPRESSED?
NALCN, and probably UNC-79, UNC-80, and NLF-1, is widely
expressed throughout the CNS in mammals (Lee et al., 1999;
Swayne et al., 2009; Kang et al., 2011). To better assess the physio-
logical role of NALCN, it is crucial to identify whether expression
is restricted to some specific neuronal populations. In addition,
NALCN is localized along the axons in C. elegans and in synap-
tic regions in D. melanogaster (Nash et al., 2002; Humphrey et al.,
2007; Yeh et al., 2008), but the neuronal localization of NALCN
channel proteins in mammals is unknown. The development of
specific antibodies for immunohistochemistry experiments will
be crucial for this purpose.
LACK OF PHARMACOLOGY OF NALCN BUT RELEVANCE OF NALCN AS A
DRUG TARGET
To date, no specific pharmacology for NALCN has been reported
and this clearly represents a significant hurdle in the study of
NALCN properties and activity. The discovery of specific NALCN
agonists/antagonists is critically needed. Such molecules would
be tools to investigate NALCN’s physiological roles and may
also hold interest to develop innovative therapeutic strategies.
Whether the NALCN channelosome represents a drug target of
interest remains unclear at the present time. Considering that
NALCN channel is expressed in pancreatic islets, both in α- and
β-cells, and is possibly involved in the regulation of insulin secre-
tion (Kutlu et al., 2009 and http://t1dbase.org; Swayne et al.,
2010), targeting NALCN might be relevant to treat type 2 dia-
betes. It is tempting to speculate that agonists of NALCN would
have beneficial effects in pancreatic β-cells on insulin secretion
(reviewed in Gilon and Rorsman, 2009). NALCN blockers might
be relevant to treat pain considering that SP plays a pivotal role in
the transmission of noxious stimuli in the spinal cord (reviewed
in Seybold, 2009) and thatNALCN is highly expressed in the dor-
sal spinal cord compared to the ventral spinal cord (Sun et al.,
2002). Based on the potential implication of NALCN channel
in human physiology and diseases, its pharmacological targeting
might also be relevant to treat epilepsy, bowell motility disorders,
osmoregulation disorders and psychiatric disorders.
SUMMARY
The NALCN channelosome is vital in mammals: homozygous
mutant mice exhibit neonatal lethal phenotype and NALCN plays
a crucial role in neuronal excitability. NALCN is involved in
the regulation of resting membrane potential and is modulated
by hormones and neurotransmitters. In the present article, we
provide an extensive review of the literature describing the molec-
ular and functional properties of the NALCN channelosome, the
various phenotypes observed in NALCN animal models, as well
as the recent implications of NALCN in human diseases. We also
discuss how NALCN could represent a therapeutic target to treat
a wide variety of human diseases, especially neurological and psy-
chiatric diseases. Unfortunately, the lack of specific pharmacology
is clearly a brake to all the NALCN investigations. In the coming
years, the expected development of selective agonists/antagonists,
as well as new animal models, should foster our understanding of
the functional properties and physiological roles of the NALCN
channelosome.
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